Bioniz Therapeutics, Inc.

Who: Equillium, Inc. / Metacrine, Inc. What: Equillium will acquire Metacrine in an all-stock transaction, but it will seek a strategic partner to develop the target company’s Phase II-ready FXR a

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie Continues Development Of Novel S

Back To Rising Leaders Gallery In this installment of In Vivo ’s 2021 Rising Leaders series, we hear from Nazli Azimi, founder and CEO of Bioniz Therapeutics, Inc. . Based in Irvine, California, th

Back To Rising Leaders Gallery Marking the second edition of the ‘Rising Leaders’ list, In Vivo has highlighted entrepreneurs and innovators who represent the next wave of creativity in health care